Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP649 | DOI: 10.1530/endoabs.110.EP649

ECEESPE2025 ePoster Presentations Endocrine Related Cancer (100 abstracts)

Parathyroid carcinoma synchronous with multifocal papillary thyroid microcarcinoma presenting as recurrent retropharyngeal hematoma in 45 years old woman

Magdalena Matejkova Behanova 1 , Petr Lastuvka 1 , Josef Vcelak 2 , Kamila Vesela 2 , Renata Chmelova 1 , Jiri Oskar Zmek 1 & Jan Plzak 1


1Motol University Hospital, Clinic of Nuclear Medicine and Endocrinology, Prague, Czech Republic; 2Institute of Endocrinology, Prague, Czech Republic


JOINT1005

Introduction: Spontaneous retropharyngeal hematoma is a rare entity that can be caused, among others, by the rupture of enlarged parathyroid gland. Only about 40 cases of spontaneous parathyroid hemorrhage have been reported in the literature. Most of them were parathyroid adenomas, with only a few cases of carcinoma described. Parathyroid carcinoma is very rare disease with incidence 3-10 cases/10 million annually. Synchronous parathyroid carcinoma and thyroid carcinoma are extremely uncommon and the cause of its coexistence is unknown.

Case Report: 45 years old woman was referred to emergency for sore throat and dysphagia. She had a history of similar event two years ago, which was diagnosed as retropharyngeal hematoma, managed conservatively without further investigation (serum calcium not tested). Actual CT from 4/2024 showed a neck mass 42x36x20mm compressing and deviating the right lobe of the thyroid gland. Laboratory: calcium 2,93 mmol/l (normal range 2,15 - 2,55), PTH 35,45 pmol/l (normal range 1,3 - 7,6), thyroid function normal. Neck ultrasound showed the same mass as CT and multinodular enlarged right thyroid lobe. Resection of the cervical mass and right hemithyroidectomy were provided in 6/2024. Histopathology: parathyroid carcinoma and two papillary thyroid carcinomas (PTC) 3 and 1 mm. The left hemithyroidectomy followed in 9/2024 with finding of another PTC 3 mm. Due to the presence of two cancers genetic testing was indicated. The patient was found to have a likely pathogenic germline frameshift variant in the tumour suppressor gene POT 1 Lys384ValfsTer15 in a heterozygous state by whole-exome sequencing. It is known from the literature that loss of the tumour suppressor telomere shortening mechanism caused by autosomal dominant disruption of the POT1 gene leads to clonal population expansion and genomic instability, which predisposes to a higher risk of cancer. Molecular genetic testing of the resected cancers will follow.

Conclusion: We present a case of recurrent retropharyngeal hematoma of the parathyroid origin. The diagnosis was established after the disease relapsed two years later. Laboratory analysis of serum calcium should be considered as a part of investigation in nontraumatic cervical hemorrhage. The germline mutation in the tumour suppressor gene POT 1 in a heterozygous state predisposes to a higher risk of cancer and probably caused both parathyroid carcinoma and multifocal papillary thyroid carcinoma in this patient. Supported by Ministry of Health Czech Republic - DRO (Institute of Endocrinology - EÚ, 00023761).

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches